-
Bradykinin (BA5201): Technical Guide for Vascular Assays
2026-04-23
Bradykinin (SKU BA5201) is a rigorously specified endothelium-dependent vasodilator peptide for controlled laboratory research into vascular permeability, smooth muscle contraction, and inflammation processes. It is not intended for diagnostic or clinical applications, and researchers should follow precise handling and storage protocols to ensure assay reliability.
-
Phosphatase Inhibitor Cocktail 1: Elevating Phosphoproteomic
2026-04-22
Phosphatase Inhibitor Cocktail 1 (100X in DMSO) from APExBIO sets a new bar for protein phosphorylation preservation, enabling high-fidelity phosphoproteomic and signaling research. Its robust inhibition profile and workflow-tuned formulation provide unmatched protection against protein dephosphorylation, streamlining Western blot, co-IP, and kinase assay pipelines.
-
Sildenafil Citrate: Advancing Proteoform-Specific Vascular R
2026-04-22
This thought-leadership article explores how Sildenafil Citrate, a potent cGMP-specific phosphodiesterase type 5 inhibitor, enables translational researchers to dissect complex, proteoform-specific signaling in vascular biology. Integrating mechanistic insight, proteomics advances, and workflow guidance, it offers strategic recommendations for leveraging this tool in high-impact, precision-driven studies.
-
Bradykinin as an Endothelium-Dependent Vasodilator: Applied
2026-04-21
Bradykinin stands at the forefront of vascular biology as a versatile endothelium-dependent vasodilator, unlocking advanced experimental possibilities in blood pressure, permeability, and pain mechanism research. This article details practical workflows, troubleshooting strategies, and the translational impact of APExBIO’s rigorously validated Bradykinin product for reproducible, high-clarity data.
-
CYR61 via Migrasomes Restores Osteogenic Function in IR BMSC
2026-04-21
This study identifies the extracellular matrix protein CYR61, delivered through migrasomes, as a key regulator of migration and osteoblastic differentiation in irradiated bone marrow mesenchymal stem cells (BMSCs). These findings reveal a novel mechanism for repairing radiation-induced bone defects, with practical implications for osteoradionecrosis therapies.
-
Kite-Shaped Molecules Inhibit SARS-CoV-2 Entry Post-Attachme
2026-04-20
Chan et al. identified a group of structurally related, FDA-approved 'kite-shaped' molecules that block SARS-CoV-2 cell entry at a post-attachment step, offering new insights for rapid drug repositioning. Their findings highlight the utility of pharmacophore modeling for predicting antiviral activity against coronaviruses, with implications for pandemic response.
-
Necrostatin 2 (Nec-2): Precision Necroptosis Inhibition in R
2026-04-20
Necrostatin 2 (Nec-2) empowers researchers to dissect necroptotic cell death pathways and optimize ischemic stroke models with unmatched specificity. This guide delivers actionable workflows, troubleshooting essentials, and a bridge to new frontiers in membrane and immune modulation.
-
Cy5-UTP: High-Sensitivity RNA Labeling for Advanced FISH
2026-04-19
Cy5-UTP (Cyanine 5-uridine triphosphate) sets a new benchmark in in vitro transcription RNA labeling, providing vivid, direct fluorescence for demanding applications such as FISH, dual-color expression arrays, and single-molecule studies. Its robust incorporation and emission profile streamline probe synthesis, enabling sensitive, multiplexed RNA detection and troubleshooting strategies for complex workflows.
-
Annexin V-Cy5/DAPI Apoptosis Kit: Optimizing Cell Death Dete
2026-04-18
The Annexin V-Cy5/DAPI Apoptosis Kit empowers rapid and precise differentiation between apoptotic and necrotic cells, streamlining experimental workflows with high sensitivity. Learn how to leverage this APExBIO tool for advanced apoptosis assays, protocol optimization, and troubleshooting in translational research.
-
CDC42 Drives HBV Entry via NTCP Trafficking and Macropinocyt
2026-04-17
This study reveals that CDC42, a Rho GTPase, is essential for hepatitis B virus (HBV) entry by promoting the trafficking of NTCP to the plasma membrane and enabling macropinocytosis. These findings clarify the molecular mechanisms of HBV entry and highlight CDC42 as a potential antiviral target.
-
Lycopene Mitigates DON-Induced Gut Injury via ERK Pathway Mo
2026-04-16
This study demonstrates that lycopene protects intestinal epithelial cells from deoxynivalenol (DON)-induced barrier dysfunction and NLRP3 inflammasome activation by targeting the ERK signaling pathway. The findings provide mechanistic insight into lycopene’s anti-inflammatory action and highlight ERK as a potential therapeutic target for DON-induced enterotoxicity.
-
Bradykinin: Technical Guide for Endothelium-Dependent Vasodi
2026-04-15
Bradykinin (SKU BA5201) provides a controlled, research-grade source of a potent endothelium-dependent vasodilator peptide for in vitro studies of vascular permeability, smooth muscle contraction, and inflammation signaling. This product is recommended for protocols requiring precise modulation of endothelial responses and is not intended for diagnostic or clinical use. Researchers should avoid long-term storage of solutions and ensure appropriate workflow controls for stability and reproducibility.
-
HotStart™ 2X Green qPCR Master Mix: Mechanism & Evidence
2026-04-14
HotStart™ 2X Green qPCR Master Mix delivers precise, reproducible nucleic acid quantification using a robust antibody-mediated hot-start mechanism. This SYBR Green qPCR master mix enhances specificity and sensitivity for real-time PCR gene expression analysis, RNA-seq validation, and other molecular applications.
-
Molnupiravir Inhibits Bourbon Virus: Insights from Mouse Mod
2026-04-13
This study provides the first in vivo evidence that molnupiravir, a broad-spectrum antiviral, suppresses Bourbon virus (BRBV) replication and pathology in susceptible mice. The findings highlight a potential therapeutic avenue for an emerging tick-borne threat lacking approved treatments, with implications for antiviral evaluation workflows in RNA virus research.
-
P2RX1 Drives Mitochondrial Apoptosis in Ph+ ALL via CaMKII a
2026-04-13
This study uncovers how P2RX1 overexpression sensitizes Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) cells to mitochondrial apoptosis by disrupting calcium signaling and inhibiting the PI3K/Akt pathway. These mechanistic insights highlight P2RX1 as a promising molecular target and inform the refinement of apoptosis detection workflows in leukemia research.